BTN3A1 靶点蛋白|抗体药物|临床药物信息

BTN3A1信息

英文名称：Butyrophilin subfamily 3 member A1
中文名称：嗜乳脂蛋白家族亚型3成员A1
靶点别称：BTF5，BTN3A1，CD_antigen，BTN3.1，BT3.1，DJ45P21.3 (Butyrophilin， Subfamily 3， Member A1)，Butyrophilin， Subfamily 3， Member A1，CD277 Antigen

上市药物数量：0
临床药物数量：1
最高研发阶段：临床二期

BTN3A1产品列表

筛选结果

产品库

在线 (3)

物种

标签

属性

Protein (3)

标记

货号	物种	产品描述
BT1-H5255	Human	Human BTN3A1 / CD277 Protein, Fc Tag (MALS verified)
BT1-H82F7	Human	Biotinylated Human BTN3A1 / CD277 Protein, Fc,Avitag™
BT1-C52H3	Cynomolgus	Cynomolgus BTN3A1 / CD277 Protein, His Tag

BTN3A1 分子别名

BTN3A1,CD277,BTF5

BTN3A1 分子背景

Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.

BTN3A1 前沿进展

BTN3A1临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
ICT-01(Imcheck Therapeutics)	ICT-01	临床二期	ImCheck Therapeutics SAS	实体瘤, 肿瘤, 淋巴瘤	详情

会议日历

会议一览

BTN3A1